Net selling: insiders sold $11.3M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position and insiders have been net selling.
Buys/Adds (2)
Qube Research
$179.9M
added
Susquehanna
$51.7M
added
Sells/Trims (1)
Millennium
$271.7M
trimmed
Sells (1)
Top-trader positions in NVT could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Jul 31, 2026
Financial period
Q2
Earnings per share
$1.16 expected
Revenue
Financial statements: Alpha Vantage
Estimates as of Oct 24, 2026
EPS expected
$1.36 to $1.44
Revenue expected
16 analysts
Last 30 days
Analysts raising estimates
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 31, 2026 | $1.45 / $1.16Alpha Vantage | +25.00% beat | $1.47B No estimate | Unavailable |
| Mar 31, 2026 | May 1, 2026 | $1.09 / $0.94Alpha Vantage | +15.96% beat | $1.24B No estimate | Unavailable |
| Dec 31, 2025 | Feb 6, 2026 | $0.90 / $0.90Alpha Vantage | +0.00% in line | $1.07B No estimate | Unavailable |
| Sep 30, 2025 | Oct 31, 2025 | $0.91 / $0.88Alpha Vantage | +3.41% beat | $1.05B No estimate | Unavailable |
| Jun 30, 2025 | Aug 1, 2025 | $0.86 / $0.79Alpha Vantage | +8.86% beat | $963.1M No estimate | Unavailable |
| Mar 31, 2025 | May 2, 2025 | $0.67 / $0.66Alpha Vantage | +1.52% beat | $809.3M No estimate | Unavailable |
| Dec 31, 2024 | Feb 6, 2025 | $0.59 / $0.59Alpha Vantage | +0.00% in line | $752.2M No estimate | Unavailable |
| Sep 30, 2024 | Nov 1, 2024 | $0.63 / $0.81Alpha Vantage | -22.22% miss | $782.0M No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.05B | $1.07B | $1.24B | $1.47B |
| Cost of what it sold | $659.3M | $677.8M | $796.4M | $913.3M |
| Gross profit | $394.7M | $388.9M | $445.6M | $558.0M |
| What it spent | ||||
| Research and development | $20.6M | $21.3M | $22.7M | $24.5M |
| Sales and admin | $207.8M | $203.8M | $227.2M | $232.8M |
| Other operating costs | — | — | -$6.0M | — |
| Total operating expenses | $228.4M | $225.1M | $243.9M | $257.3M |
| What was left | ||||
| Operating profit | $166.3M | $163.8M | $201.7M | $300.7M |
| Interest on debt | $20.9M | $19.1M | $17.5M | $17.4M |
| Profit before tax | $144.2M | $156.3M | $176.9M | $282.0M |
| Tax | $25.2M | $40.5M | $36.5M | $66.2M |
| Net profit | $121.2M | $118.8M | $140.7M | $215.9M |
| EBITDA | $223.8M | $232.2M | $252.3M | $357.9M |
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace